Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.

Molecular pharmacology - 1 Sept 2009

Dorn Gerald W, Liggett Stephen B

Abstract excerpt

One of the goals of pharmacogenomics is the use of genetic variants to predict an individual's response to treatment. Although numerous candidate and genome-wide associations have been made for cardiovascular response-outcomes, little is known about how a given polymorphism imposes the phenotype. Such mechanisms are important, because they tie the observed human response to specific signaling alterations and thus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to Amino Acid Sequence
Share to Chronic Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Failure

Share to Mice, Transgenic

Share to Polymorphism, Genetic

Share to Receptors, Adrenergic, beta-1

Source

Open in PubMed Open full text

Identifiers

PMID: 19491328
DOI: 10.1124/mol.109.056572
PMCID: PMC2730380

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.PMID 19491328Read ↗

Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions.Semantic proximity Read ↗

Pharmacogenetics of heart failure.Semantic proximity Read ↗

Pharmacogenomics of beta1-adrenergic receptor polymorphisms in heart failure.Semantic proximity Read ↗

Mechanisms of Disease: β-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failureSemantic proximity Read ↗

Heart failure and personalized medicine.Semantic proximity Read ↗

Genetics and pharmacogenetics in heart failure.Semantic proximity Read ↗

[Adrenergic receptor polymorphisms in heart failure: what can genetics explain?].Semantic proximity Read ↗

State of play of pharmacogenetics and personalized medicine in heart failure.Semantic proximity Read ↗

Genetics of common forms of heart failure.Semantic proximity Read ↗

The future of pharmacogenetics in the treatment of heart failure.Semantic proximity Read ↗

Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.Semantic proximity Read ↗

Genetic variation of human adrenergic receptors: from molecular and functional properties to clinical and pharmacogenetic implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.